论文部分内容阅读
为了探讨肝硬化患者院内感染与医院抗生素使用的关系,笔者对1996～1998年三年间在该院传染科住院的200例肝硬化患者进行了前瞻性研究,现将结果报告如下。1 材料与方法1.1 临床资料 200例患者男162例,女38例。年龄27～72岁,平均年龄49.5岁。1.2 分组及治疗 患者入院后随机分组,第一组在保肝支持治疗及对症治疗的同时,间断预防性应用抗生素。第二组只给予保肝治疗及对症治疗。保肝支持治疗主要使用肝细胞生长素、强力宁、维生素C、维生素K等静脉滴注;对症处理利尿药、助消化药等的应用。预防性应用抗生素主要选用抑
In order to investigate the relationship between nosocomial infections and the use of antibiotics in patients with cirrhosis, the author conducted a prospective study on 200 cirrhotic patients hospitalized in the Department of Infectious Diseases in the hospital from 1996 to 1998. The results are reported as follows. 1 Materials and Methods 1.1 Clinical data 200 patients were 162 males and 38 females. Age 27 to 72 years old, average age 49.5 years old. 1.2 grouping and treatment of patients randomized into hospital, the first group in the liver support and symptomatic treatment of symptomatic treatment, intermittent prophylactic antibiotics. The second group only give liver protection and symptomatic treatment. Hepatoprotective support The main use of hepatocyte growth factor, strong Ning, vitamin C, vitamin K and other intravenous drip; symptomatic treatment of diuretics, digestive drugs and other applications. Preventive antibiotics use the main suppression